What Researchers Did
Researchers retrospectively analyzed clinical records of 176 patients with refractory radiation-induced hemorrhagic cystitis treated with hyperbaric oxygen therapy over 15 years.
What They Found
After an average of 37 sessions, 89.8% of the 176 patients experienced resolution of hematuria, with only 1.7% reporting adverse events. Treatment success was statistically associated with the need for transfusion therapy (P=0.026) and the number of hyperbaric oxygen sessions (P=0.042).
What This Means for Canadian Patients
Canadian patients suffering from refractory radiation-induced hemorrhagic cystitis may find hyperbaric oxygen therapy to be a successful and safe treatment option. This therapy could offer relief from persistent hematuria, potentially improving quality of life for those affected by this challenging condition.
Canadian Relevance
This study was conducted in Portugal and has no direct Canadian connection.
Study Limitations
A limitation of this study is its retrospective design, which may be subject to selection bias and incomplete data.